Charles River Laboratories International, Inc. (CRL)

CRL Stock Forecast

Stock Price Forecast

The 14 analysts that cover CRL stock have a consensus rating of "Buy" and an average price target of $184.85, which forecasts a 4.38% increase in the stock price over the next year. The lowest target is $140 and the highest is $250.

Price Target: $184.85 (+4.38%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$140	$184.85	$182	$250
Change	-20.95%	+4.38%	+2.77%	+41.16%

Analyst Ratings

The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	2	1	1	2	2	3
Buy	0	0	0	0	0	1
Hold	11	14	14	13	13	10
Sell	0	0	0	0	0	0
Strong Sell	2	0	0	0	0	0
Total	15	15	15	15	15	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ross Muken Evercore ISI Group	Evercore ISI Group	Buy Maintains $170 → $180	Buy	Maintains	$170 → $180	+1.64%	Jul 9, 2025
Patrick Donnelly Citigroup	Citigroup	Hold → Strong Buy Upgrades $150 → $200	Hold → Strong Buy	Upgrades	$150 → $200	+12.93%	Jul 9, 2025
Jamie Clark Redburn Atlantic	Redburn Atlantic	Hold → Strong Buy Upgrades $188 → $182	Hold → Strong Buy	Upgrades	$188 → $182	+2.77%	May 23, 2025
Luke Sergott Barclays	Barclays	Hold Maintains $145 → $155	Hold	Maintains	$145 → $155	-12.48%	May 8, 2025
Eric Coldwell Baird	Baird	Hold Maintains $118 → $140	Hold	Maintains	$118 → $140	-20.95%	May 8, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.94B

Decreased by -2.79%

from 4.05B

Revenue Next Year

4.04B

Increased by 2.49%

from 3.94B

EPS This Year

9.70

Increased by 4,748.00%

from 0.20

EPS Next Year

10.36

Increased by 6.85%

from 9.70

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 26, 2020	Dec 25, 2021	Dec 31, 2022	Dec 30, 2023	Dec 28, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.92B	3.54B	3.98B	4.13B	4.05B	3.94B	4.04B	4.24B
Revenue Growth	11.55%	21.08%	12.31%	3.86%	-1.92%	-2.79%	2.49%	5.13%
EPS	7.20	7.60	9.48	9.22	0.20	9.70	10.36	11.32
EPS Growth	42.01%	5.56%	24.74%	-2.74%	-97.83%	4,748.00%	6.85%	9.28%
Forward PE	-	-	-	-	-	18.27	17.09	15.64
No. Analysts	-	-	-	-	-	21	21	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	4.2B	4.3B	4.8B
Avg	3.9B	4.0B	4.2B
Low	3.8B	3.8B	3.9B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	3.1%	9.3%	18.7%
Avg	-2.8%	2.5%	5.1%
Low	-6.8%	-4.2%	-3.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	10.29	11.48	12.75
Avg	9.70	10.36	11.32
Low	9.11	8.89	10.05

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	5,045.0%	18.4%	23.0%
Avg	4,748.0%	6.9%	9.3%
Low	4,457.0%	-8.3%	-3.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.